Cyclic AMP can promote APL progression and protect myeloid leukemia cells against anthracycline-induced apoptosis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cyclic AMP can promote APL progression and protect myeloid leukemia cells against anthracycline-induced apoptosis
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 4, Issue 2, Pages e516-e516
Publisher
Springer Nature
Online
2013-02-28
DOI
10.1038/cddis.2013.39
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cyclin-dependent kinases 7 and 9 specifically regulate neutrophil transcription and their inhibition drives apoptosis to promote resolution of inflammation
- (2012) A E Leitch et al. CELL DEATH AND DIFFERENTIATION
- Advances in therapies for acute promyelocytic leukemia
- (2011) Tomohiko Kamimura et al. CANCER SCIENCE
- Peculiarities of cell death mechanisms in neutrophils
- (2011) B Geering et al. CELL DEATH AND DIFFERENTIATION
- Therapeutic Advances in Acute Myeloid Leukemia
- (2011) Alan Burnett et al. JOURNAL OF CLINICAL ONCOLOGY
- Pronounced Hypoxia in Models of Murine and Human Leukemia: High Efficacy of Hypoxia-Activated Prodrug PR-104
- (2011) Juliana Benito et al. PLoS One
- Cyclic AMP induces IPC leukemia cell apoptosis via CRE-and CDK-dependent Bim transcription
- (2011) S Huseby et al. Cell Death & Disease
- Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome
- (2010) M. A. Sanz et al. BLOOD
- Neutrophil Apoptosis: Relevance to the Innate Immune Response and Inflammatory Disease
- (2010) Sarah Fox et al. Journal of Innate Immunity
- Prostaglandin E2, an Immunoactivator
- (2010) Daiji Sakata et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Functional involvement of RINF, retinoid-inducible nuclear factor (CXXC5), in normal and tumoral human myelopoiesis
- (2009) F. Pendino et al. BLOOD
- Activation of cAMP signaling inhibits DNA damage-induced apoptosis in BCP-ALL cells through abrogation of p53 accumulation
- (2009) E. H. Naderi et al. BLOOD
- Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML
- (2009) J. Zhou et al. BLOOD
- Purine analogs sensitize the multidrug resistant cell line (NCI-H460/R) to doxorubicin and stimulate the cell growth inhibitory effect of verapamil
- (2009) Milica Pešić et al. INVESTIGATIONAL NEW DRUGS
- Identification of Novelin VivoPhosphorylation Sites of the Human Proapoptotic Protein BAD
- (2009) Lisa Polzien et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- BAD: undertaker by night, candyman by day
- (2009) N N Danial ONCOGENE
- Abolition of stress-induced protein synthesis sensitizes leukemia cells to anthracycline-induced death
- (2008) G. Gausdal et al. BLOOD
- Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
- (2008) M. A. Sanz et al. BLOOD
- Protein kinase A as a biological target in cancer therapy
- (2008) Silvio Naviglio et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Arsenic trioxide inhibits ATRA-induced prostaglandin E2 and cyclooxygenase-1 in NB4 cells, a model of acute promyelocytic leukemia
- (2008) A Habib et al. LEUKEMIA
- Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation
- (2008) Rihab Nasr et al. NATURE MEDICINE
- The BCL-2 protein family: opposing activities that mediate cell death
- (2007) Richard J. Youle et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now